Related Experiment Video
Updated: Aug 4, 2025

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Role of Intra-arterial Nitroglycerin (Post Procedural, Prehemostasis) to Reduce Radial Artery Occlusion after
M K Islam1, M J Uddin, A Momen
1Dr Dewan Mohammmad Karimul Islam, MD, Department of Cardiology, National Institute of Cardiovascular Diseases (NICVD), Dhaka, Bangladesh;
Insights
Intra-arterial nitroglycerin administered after transradial procedures significantly reduces radial artery occlusion (RAO). This intervention lowers RAO incidence compared to standard compression, preserving radial artery patency.
Area of Science:
- Cardiology
- Vascular Medicine
- Interventional Cardiology
Background:
- Transradial access (TRA) is a common approach for coronary procedures.
- Radial artery occlusion (RAO) is a potential complication following TRA.
- Preserving radial artery patency is crucial for future vascular access.
Purpose of the Study:
- To evaluate the efficacy of intra-arterial nitroglycerin in preventing RAO after TRA.
- To determine if nitroglycerin administration impacts radial artery patency post-procedure.
Main Methods:
- A prospective observational study involving 200 patients undergoing coronary angiography or percutaneous coronary intervention via TRA.
- Group I (102 patients) received intra-arterial nitroglycerin before sheath removal; Group II (98 patients) did not.
- Radial artery patency was assessed using Doppler ultrasound the day after the procedure.
Main Results:
- The overall incidence of RAO one day post-TRA was 13.5%.
- Group I showed a significantly lower RAO incidence (8.8%) compared to Group II (18.4%, p=0.04).
- Diabetes mellitus, prolonged hemostatic compression (>2 hours), and longer procedure times were predictors of RAO.
Conclusions:
- Intra-arterial nitroglycerin administration at the end of transradial catheterization effectively reduces the incidence of radial artery occlusion.
- This simple intervention can help preserve radial artery patency after coronary procedures.
- Optimizing hemostatic techniques and considering patient comorbidities are important for minimizing RAO risk.
Abstract:
The study was intended to evaluate efficacy of Intra-arterial nitroglycerin through the sheath at the end of a transradial procedure to preserve the patency of the radial artery. This prospective observational study was done in the Department of Cardiology, National Institute of Cardiovascular Diseases (NICVD), Dhaka, Bangladesh from May 2017 to April 2018, by including a total 200 patients undergoing coronary procedures (CAG and / or PCI) through TRA. RAO was defined as an absence of antegrade flow or monophasic flow or invert flow on Doppler study. In this study 102 patients (Group I) received 200 mcg intra-arterial nitroglycerine, prior to trans-radial sheath removal. Another 98 patients (Group II) did not receive intra-arterial nitroglycerine prior to trans-radial sheath removal. Conventional haemostatic compression methods were applied (average 2 hours) in both groups of patients. Evaluation of radial arterial arterial blood flow by colour Doppler study was done on next day after the procedure in both groups. Results of this study in which RAO was determined by vascular doppler study showed that frequency of radial artery occlusion were 13.5% one day after transradial coronary procedures. We found the incidence was 8.8% vs. 18.4%, (p=0.04) in Group I and Group II respectively. The incidence of RAO was significantly lower in post procedural nitroglycerine group. From multivariate logistic regression analysis diabetes mellitus (p = 0.02), hemostatic compression time for more than 02 hours after sheath removal (p = <0.001) and procedure time (p = 0.02) was predictors of RAO. So, the administration of nitroglycerin at the end of a transradial catheterization reduced the incidence of RAO, as shown by 1 day after the radial procedure by doppler ultrasound.
Related Concept Videos
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Antihypertensive Drugs: Vasodilators
Angina IV: Management
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...

